Adrenomedullin (ADM), a potent vasodilatory peptide hormone produced by endothelial
cells and several other mammalian tissues (heart, lung, kidney, bone, adrenals, etc.) exerts …

Background Mid-regional pro-adrenomedullin (MR-proADM) is useful for risk stratification in
patients with sepsis and respiratory infections. The study's purpose was to assess the …

Background Mid-regional proadrenomedullin (MR-proADM) is a biomarker released
following endothelial damage. Studies have shown a correlation in predicting coronavirus …

Objective To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in
comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate …

Aims There is a lack of biomarkers validated for assessing clinical deterioration in patients
with COVID-19 on presentation to secondary or tertiary care. This evaluation looked at the …

Background Mid-regional pro-adrenomedullin (MR-proADM), an endothelium-related
peptide, is a predictor of death and multi-organ failure in respiratory infections and sepsis …

Background Although there is increasing understanding of the changes in the laboratory
parameters of Coronavirus disease 2019 (COVID-19), the correlation between circulating …

Objective. To determine the predictive value of mid-regional proadrenomedullin (MR-
proADM) in comparison with routine clinical and laboratory data in patients with the new …

Background To determine the predictive value of mid-regional pro-adrenomedullin (MR-
proADM) compared to routine clinical and laboratory parameters in patients with COVID-19 …

OBJECTIVE: This study evaluated the ability of mid-regional proadrenomedullin (MR-
proADM) to identify disease severity in Coronavirus disease 2019 (COVID-19) patients in …